feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Houston severe weather threat

trending

Powerball jackpot rises to $740M

trending

Cyclone Ditwah heads towards India

trending

Netflix cancels Good Times revival

trending

Chicago flights cancelled, snowstorm

trending

Sevilla, Betis in LaLiga derby

trending

Saints face Dolphins today

trending

Chelsea Arsenal Premier League clash

trending

Verstappen wins Qatar Grand Prix

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Nose Drops Fight Deadly Brain Cancer

Nose Drops Fight Deadly Brain Cancer

24 Nov

•

Summary

  • Nasal drops deliver tumor-fighting medicine to the brain.
  • Method effectively treats glioblastoma by boosting immune response.
  • Technology uses engineered nanostructures called spherical nucleic acids.
Nose Drops Fight Deadly Brain Cancer

A novel approach using nasal drops shows promise for treating aggressive brain cancers, offering a non-invasive alternative to current therapies. Researchers have developed a technology that delivers tumor-fighting medicine directly to the brain through the nose, effectively boosting the immune system's response against glioblastoma in mice.

This new method employs spherical nucleic acids (SNAs), engineered nanostructures that activate the stimulator of interferon genes (STING) pathway. This activation is crucial for 'warming up' cold tumors, which are typically resistant to immunotherapy, thereby enhancing the efficacy of treatments like checkpoint inhibitors.

The development marks a significant step toward more effective and less invasive treatments for glioblastoma. Further studies are ongoing to determine how these findings translate to human patients, offering hope for safer and more potent therapies for brain cancer and other immune-resistant malignancies.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Researchers are using specially engineered nasal drops to deliver tumor-fighting medicine directly to the brain, boosting the immune response against glioblastoma.
SNAs are nanostructures that activate the STING pathway, reprogramming the brain's immune microenvironment to better fight glioblastoma tumors.
The nasal spray technology is currently in development and has shown effectiveness in mice studies; it is not yet consumer-ready for clinical use.

Read more news on

Healthside-arrow

You may also like

Boost Activity, Cut Dementia Risk by 45%

28 Nov • 12 reads

article image

Dual Cancer Fight: Lung Tumor Found Alongside Breast Cancer

28 Nov • 13 reads

article image

Young Adults Face Cancer Spread Risk

28 Nov • 12 reads

article image

Alzheimer's Breakthrough: Lithium May Reverse Memory Loss

26 Nov • 31 reads

article image

Diabetes & MASLD: Power Plants Fail Fuel Switch

25 Nov • 24 reads

article image